The World Health Organization launched the first clinical trial on Tuesday to test whether an antiviral drug can prevent infection in people exposed to the Bundibugyo strain of Ebola in the Democratic Republic of Congo, as the outbreak continues to outpace response efforts and spread beyond known chains of transmission.
The first clinical trial is under way of an antiviral drug's effectiveness in people exposed to the deadly Ebola strain spreading in the Democratic Republic of Congo, the WHO said Tuesday.